[ad_1]
The Korea Food and Drug Administration has approved two clinical trials for the corona vaccine and treatment
The Ministry of Food Safety and Drugs has announced that it has approved a Phase 1 clinical trial plan for a corona vaccine19 developed in Korea and a Phase 2 clinical trial plan for a therapeutic agent.
The recently approved clinical trial of the vaccine is SK Bioscience’s genetically modified vaccine, which is designed to evaluate the safety and immunity of healthy adults.
In addition, the clinical trial of the treatment is a drug that is being developed as a new drug for the treatment of asthma by Donghwa Pharmaceutical.
As a result, there are 30 cases of approval for clinical trials for Corona 19 in Korea, of which 22 treatment cases and 3 vaccine cases are ongoing.
Yonhap News TV article inquiries and reports: katok / line jebo23
(End)
Source link
